Programmed cell death in inflammation: interactions and holistic perspective
7 affiliations
- 1Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, China
- 2School of Anesthesiology, Naval Medical University, Shanghai, China
- 3Department of Anesthesiology, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China
- 4National Key Laboratory of Immunity and Inflammation, Naval Medical University, Shanghai, China
- 5Faculty of Naval Medicine, Naval Medical University, Shanghai, China
- 6Department of Biomedical Sciences, Pusat Kanser Tun Abdullah Ahmad Badawi, Universiti Sains Malaysia, Kepala Batas, Malaysia
- 7Department of Anesthesiology, Southwest Hospital, Army Medical University, Chongqing, China
Abstract
Programmed cell death (PCD) is a major regulatory mechanism that maintains tissue homeostasis and immune balance and strongly influences the initiation, progression and resolution of inflammation. Although apoptosis, pyroptosis, necroptosis and ferroptosis are individual PCD modes that are regulated by different molecular mechanisms, they are not mutually exclusive in inflammatory microenvironments. Instead, these pathways are linked via common signaling mediators and regulatory nodes that enable crosstalk, compensatory activation and context-dependent fine-tuning. It is evident that apoptosis, pyroptosis and necroptosis can be coordinated within defined inflammatory platforms, as exemplified by concepts such as PANoptosis. Pathway-specific modeling is inadequate for inflammatory diseases involving multiple PCD modalities, metabolic and organelle stress, immune-cell interactions and tissue-level changes that molecular models cannot capture. Here, an integrated cell death network (ICDN) paradigm is presented as an organizational schema describing how various types of PCD are coregulated through common regulatory pathways in inflamed tissues. This framework does not identify a new mode of cell death per se but rather integrates pathway compensation following extracellular perturbations, disease-specific inflammatory responses, and susceptibility to therapeutic intervention at common network nodes. This review defines the molecular mechanisms and crosstalk of inflammatory pyroptosis, apoptosis, and necroptosis pathways; links recent advances in death modality applications for specific diseases to the ICDN framework; and highlights important current limitations that require further examination, including the need for stronger evidence of dynamic switching across cell death modalities, spatial architecture during inflammation, and reconfiguration at both the multiprotein complex and network levels, such as inflammasome networks.
Related
- Holistic Design of Selective Photoenzymes with Genetically Programmed Sensitizers
- Regulatory mechanisms of programmed cell death in hyperuricaemia and their disease relevance
- Mitochondria as the core regulator of cell death: from classical programmed cell death to the novel mitoxyperiosis pathway
- Programmed cell death: immune regulatory mechanisms in periodontitis and rheumatoid arthritis.
- xNNPCD identifies regulators of programmed cell death by integrating perturbation transcriptomes with cancer dependency profiles
BibTeX
@article{zhang2026programmed,
title = {{Programmed cell death in inflammation: interactions and holistic perspective}},
author = {Wangzheqi Zhang and Chenglong Zhu and Chunzhen Li and Lizhou Song and Yan Liao and Haoling Zhang and Bin Yi and Zui Zou},
journal = {Cellular and Molecular Immunology},
year = {2026},
month = oct,
doi = {10.1038/s41423-026-01479-8},
url = {https://doi.org/10.1038/s41423-026-01479-8},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Programmed cell death in inflammation: interactions and holistic perspective
AU - Wangzheqi Zhang
AU - Chenglong Zhu
AU - Chunzhen Li
AU - Lizhou Song
AU - Yan Liao
AU - Haoling Zhang
AU - Bin Yi
AU - Zui Zou
PY - 2026
DA - 2026/10/13
JO - Cellular and Molecular Immunology
DO - 10.1038/s41423-026-01479-8
UR - https://doi.org/10.1038/s41423-026-01479-8
AB - Programmed cell death (PCD) is a major regulatory mechanism that maintains tissue homeostasis and immune balance and strongly influences the initiation, progression and resolution of inflammation. Although apoptosis, pyroptosis, necroptosis and ferroptosis are individual PCD modes that are regulated by different molecular mechanisms, they are not mutually exclusive in inflammatory microenvironments. Instead, these pathways are linked via common signaling mediators and regulatory nodes that enable crosstalk, compensatory activation and context-dependent fine-tuning. It is evident that apoptosis, pyroptosis and necroptosis can be coordinated within defined inflammatory platforms, as exemplified by concepts such as PANoptosis. Pathway-specific modeling is inadequate for inflammatory diseases involving multiple PCD modalities, metabolic and organelle stress, immune-cell interactions and tissue-level changes that molecular models cannot capture. Here, an integrated cell death network (ICDN) paradigm is presented as an organizational schema describing how various types of PCD are coregulated through common regulatory pathways in inflamed tissues. This framework does not identify a new mode of cell death per se but rather integrates pathway compensation following extracellular perturbations, disease-specific inflammatory responses, and susceptibility to therapeutic intervention at common network nodes. This review defines the molecular mechanisms and crosstalk of inflammatory pyroptosis, apoptosis, and necroptosis pathways; links recent advances in death modality applications for specific diseases to the ICDN framework; and highlights important current limitations that require further examination, including the need for stronger evidence of dynamic switching across cell death modalities, spatial architecture during inflammation, and reconfiguration at both the multiprotein complex and network levels, such as inflammasome networks.
SN - 1672-7681
SN - 2042-0226
ER -